VRTX Total assets
Total assets at Vertex Pharmaceuticals rose to $25.6B in fiscal 2025, the highest in the 5 years reported, from $22.5B in 2024.
Total assets, as filed.
SOURCE: us-gaap:Assets · EDGAR CompanyFacts · CIK 875320 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$25.6B
FY2024 $22.5B
HIGH$25.6B FY2025
LOW$13.4B FY2021
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Total assets | Change |
|---|---|---|
| FY2025 | $25.6B | +$3.1B |
| FY2024 | $22.5B | $-197M |
| FY2023 | $22.7B | +$4.6B |
| FY2022 | $18.2B | +$4.7B |
| FY2021 | $13.4B | — |
More SAME DATA, OTHER VIEWS
Total assets across coverage → · VRTX company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Shareholders' equity · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.